Metabolomics Reveals Reduction of Metabolic Oxidation in Women with Polycystic Ovary Syndrome after Pioglitazone-Flutamide-Metformin Polytherapy

Polycystic ovary syndrome (PCOS) is a variable disorder characterized by a broad spectrum of anomalies, including hyperandrogenemia, insulin resistance, dyslipidemia, body adiposity, low-grade inflammation and increased cardiovascular disease risks. Recently, a new polytherapy consisting of low-dose...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vinaixa, Maria, Rodriguez, Miguel Angel, Samino, Sara, Díaz, Marta, Beltran, Antoni, Mallol, Roger, Bladé, Cinta, Ibañez, Lourdes, Correig, Xavier, Yanes, Oscar
Formato: Artigo
Lenguaje:Inglês
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3241700/
https://ncbi.nlm.nih.gov/pubmed/22194988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0029052
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares